microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Primary ovarian cancer is a leading cause of gynecological cancer mortality.
• Serine/threonine p21-activated kinases (PAKs) influence cell morphology and cytoskeletal reorganization.
• The role of microRNA-126 (miR-126) in inhibiting ovarian cancer cell invasion via PAK4 warrants investigation.

Purpose of the Study:

• To investigate the association between miR-126 and PAK4 expression in ovarian cancer.
• To determine if miR-126 affects PAK4 levels in ovarian cancer cells.
• To explore miR-126's potential as a tumor suppressor in ovarian cancer.

Main Methods:

• Ovarian cancer SKOV3 cells were transfected with miR-126 mimics or inhibitors.
• Immunofluorescence staining was used to assess PAK4 expression levels.
• Western blot analysis quantified PAK4 protein expression.

Main Results:

• Transfection with LV3-miR-126 significantly downregulated PAK4 expression (P<0.05).
• Transfection with the miR-126 inhibitor significantly upregulated PAK4 expression (P<0.05).
• Western blot confirmed decreased PAK4 with miR-126 mimic and increased PAK4 with miR-126 inhibitor.

Conclusions:

• miR-126 expression inversely correlates with PAK4 levels in ovarian cancer cells.
• miR-126 may function as a tumor suppressor by reducing PAK4 expression.
• This study provides a foundation for targeting miR-126 to inhibit ovarian cancer progression.